| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.87B | 7.72B | 7.09B | 5.92B | 5.47B | 6.22B |
| Gross Profit | 5.49B | 5.26B | 4.71B | 3.85B | 3.52B | 4.32B |
| EBITDA | 3.95B | 3.94B | 3.33B | 2.52B | 2.31B | 3.25B |
| Net Income | 2.50B | 2.46B | 2.06B | 1.61B | 1.37B | 2.21B |
Balance Sheet | ||||||
| Total Assets | 14.73B | 15.83B | 15.51B | 14.62B | 14.35B | 14.68B |
| Cash, Cash Equivalents and Short-Term Investments | 1.51B | 2.45B | 2.97B | 2.19B | 1.86B | 1.90B |
| Total Debt | 7.31B | 7.35B | 7.75B | 7.42B | 7.86B | 7.97B |
| Total Liabilities | 11.59B | 11.63B | 11.78B | 11.15B | 11.66B | 11.76B |
| Stockholders Equity | 2.99B | 4.05B | 3.56B | 3.32B | 2.52B | 2.73B |
Cash Flow | ||||||
| Free Cash Flow | 2.99B | 2.58B | 2.52B | 1.88B | 1.19B | 1.87B |
| Operating Cash Flow | 3.08B | 2.90B | 2.84B | 2.15B | 1.47B | 2.00B |
| Investing Cash Flow | -313.00M | 2.00M | -1.06B | -247.00M | -262.00M | -2.62B |
| Financing Cash Flow | -3.48B | -3.06B | -1.45B | -1.58B | -1.21B | -122.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $8.15B | 15.04 | 27.22% | 1.49% | 6.51% | 9.85% | |
77 Outperform | $42.62B | 24.33 | -74.96% | 1.24% | 10.86% | 20.25% | |
76 Outperform | $78.85B | 29.17 | 66.74% | 0.73% | 8.95% | 20.40% | |
76 Outperform | $124.36B | 22.66 | 13.84% | 0.73% | 8.54% | 24.07% | |
69 Neutral | $6.72B | 15.43 | 30.01% | 0.84% | 8.39% | 10.06% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |